Prefilled for Bleeding

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Canadian Forces, Ottawa, Canada
Bleeding+3 More
Prefilled - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Background: While medical advances for in-hospital care rapidly evolve, a mainstay of effective pre-hospital care remains the ability to treat medical emergencies such as anaphylaxis, prolonged seizure, overdose, or uncontrolled bleeding, through rapid administration of appropriate medication. Autoinjectors are used globally to deliver medications in a timely manner, often in environments where immediate access to medical facilities is limited. Rapid administration of intramuscular medication delivery is essential where oral or intravenous delivery is either not possible or ineffective. The purpose of the proposed study seeks to determine the efficiency various types of medication injection administration.

Eligible Conditions

  • Bleeding
  • Overdose Antidote
  • Allergic Reaction

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: immediately after intervention

immediately after intervention
Change in medication Injection/delivery time for each trial
Number of injection failures and/or injuries associated with each trial
Perceived difficulty of injection based on type of system

Trial Safety

Trial Design

1 Treatment Group

Injection Scenario
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Prefilled · No Placebo Group · N/A

Injection ScenarioExperimental Group · 3 Interventions: Autoinjector, Standard Injector, Prefilled · Intervention Types: Device, Device, Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Autoinjector
2016
Completed Phase 3
~260

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: immediately after intervention
Closest Location: Canadian Forces · Ottawa, Canada
Photo of Ottawa 1Photo of Ottawa 2Photo of Ottawa 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Bleeding
0 CompletedClinical Trials

Who is running the clinical trial?

Canadian Forces Health Services Centre OttawaLead Sponsor
9 Previous Clinical Trials
1,149 Total Patients Enrolled
Gaurav Gupta, MDPrincipal InvestigatorCAF
4 Previous Clinical Trials
107 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.